EUVIMEDEUVIMED entdecken
Crossref

In Silico‐Designed G‐Quadruplex Targeting Peptide Attenuates VEGF‐A Expression, Preventing Angiogenesis in Cancer Cells

Nilanjan Banerjee, Laboni Roy, Suman Panda, Tanaya Roychowdhury, Subhrangsu Chatterjee iD

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.70018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Nilanjan Banerjee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Non-Coding Genome Group, Department of Structural Biology, CEITEC-Central European Institute of Technology, Brno, Czech Republic. Hauptthemen laut MEDLINE: G-Quadruplexes, Vascular Endothelial Growth Factor A, Neovascularization, Pathologic, Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular endothelial growth factor‐A (VEGF‐A) is a growth factor and pluripotent cytokine that promotes angiogenesis in cancer cells, transitioning to an angiogenic phenotype. The binding of VEGF‐A protein to VEGF receptors (VEGFR‐1 and VEGFR‐2) initiates a cascade of events that stimulates angiogenesis by facilitating the migration and enhancing the permeability of endothelial cells. The proximal promoter of the VEGF gene encompasses a 36‐base pair region (from −85 to −50) that can form a stable G‐quadruplex (G4) structure in specific conditions. The activity of the VEGF promoter is reliant on this structure. During cancer progression, the VEGF‐A G4 succumbs to cellular pressure and fails to maintain a stable structure. This shifts the balance to form a duplex structure, increasing the transcription rate. Earlier research has tried to develop small‐molecule ligands to target and stabilise G4, demonstrating the possibility of suppressing VEGF expression. However, they either lack specificity or toxic. Peptides, on the other hand, are significantly less studied as G4 binders. Here, we designed a peptide that successfully binds and stabilises the VEGF‐A G4 while reducing its gene expression. This further alters the expression fate of the VEGF‐A signalling cascade and blocks angiogenesis in cancer cells. We employed high‐resolution nuclear magnetic resonance (NMR) spectroscopy and molecular dynamics simulation to elucidate the chemical details of G4‐peptide interaction. In addition, we used qPCR and western blot techniques to investigate the expression pattern of the molecules implicated in the VEGF‐A signalling cascade. The study explores the intricate relationship between peptides and quadruplex structures, revealing valuable insights that can improve the design of pharmacophores targeting the dynamic quadruplex structure. The results of our study are encouraging, opening possibilities for advancements in, the characterisation and optimisation of peptides as G‐quadruplex ligands in view of their potential therapeutic uses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

G-QuadruplexesVascular Endothelial Growth Factor ANeovascularization, PathologicPeptidesHumansMolecular Dynamics SimulationCell Line, TumorPromoter Regions, GeneticNeoplasmsAngiogenesis

Stichwörter der Autor:innen

G‐quadruplexVEGF‐Aangiogenesiscancerpeptide

Substanzen

Vascular Endothelial Growth Factor APeptides

Autor:innen und Institutionen

  • Non-Coding Genome Group, Department of Structural Biology, CEITEC-Central European Institute of Technology, Brno, Czech Republic.
  • Department of Biological Science, Bose Institute, Unified Academic Campus, Kolkata, India.
  • Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Subhrangsu Chatterjee

Zitieren

APA

Banerjee, N., Roy, L., Panda, S., Roychowdhury, T., & Chatterjee, S. (2024). In Silico‐Designed G‐Quadruplex Targeting Peptide Attenuates VEGF‐A Expression, Preventing Angiogenesis in Cancer Cells. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70018

Vancouver

Banerjee N, Roy L, Panda S, Roychowdhury T, Chatterjee S. In Silico‐Designed G‐Quadruplex Targeting Peptide Attenuates VEGF‐A Expression, Preventing Angiogenesis in Cancer Cells. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.70018

BibTeX
@article{Banerjee2024,
  author = {Banerjee, Nilanjan and Roy, Laboni and Panda, Suman and Roychowdhury, Tanaya and Chatterjee, Subhrangsu},
  title = {In Silico‐Designed G‐Quadruplex Targeting Peptide Attenuates VEGF‐A Expression, Preventing Angiogenesis in Cancer Cells},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.70018}
}
Kostenlos starten →